Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

88
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
88
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

315
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
315
Renal Clearance01:23

Renal Clearance

3.1K
The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
3.1K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

538
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
538
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

1.6K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.6K
Renal Drug Excretion: Glomerular Filtration01:02

Renal Drug Excretion: Glomerular Filtration

1.6K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric clinician perspectives on clinical decision support tools for chronic kidney disease risk after preterm birth.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Meaningful Engagement of Patients in Research.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Patient Centered Technologies to Improve Hemodialysis Vascular Access Cannulation.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Kidney Disease: Improving Global Outcomes Green Dialysis Controversies Conference: A Carbon Footprint and Sustainability Report.

Kidney international reports·2026
Same author

The Associations Between Dialysis Treatment Time, Mortality, and Hospitalizations in a Large Hemodialysis Cohort.

Kidney international reports·2026
Same author

The Perspectives of Patients and Community Health Workers on the Recruitment and Retention of Latino Individuals in Research in Dialysis: A Qualitative Study.

Kidney medicine·2026

Related Experiment Video

Updated: Mar 16, 2026

Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing
10:19

Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing

Published on: February 13, 2016

11.9K

Ultrafiltration Rate Clinical Performance Measures: Ready for Primetime?

Jennifer E Flythe1,2

  • 1Department of Medicine, Division of Nephrology and Hypertension, UNC School of Medicine, University of North Carolina Kidney Center, Chapel Hill, North Carolina. jflythe@med.unc.edu.

Seminars in Dialysis
|August 17, 2016
PubMed
Summary

High ultrafiltration (UF) rates during hemodialysis are linked to poor outcomes. More research is needed to understand if lowering UF rates improves patient health and quality of life.

More Related Videos

Physiology Lab Demonstration: Glomerular Filtration Rate in a Rat
06:58

Physiology Lab Demonstration: Glomerular Filtration Rate in a Rat

Published on: July 26, 2015

18.2K
A Modified EPA Method 1623 that Uses Tangential Flow Hollow-fiber Ultrafiltration and Heat Dissociation Steps to Detect Waterborne Cryptosporidium and Giardia spp.
12:11

A Modified EPA Method 1623 that Uses Tangential Flow Hollow-fiber Ultrafiltration and Heat Dissociation Steps to Detect Waterborne Cryptosporidium and Giardia spp.

Published on: July 9, 2012

21.1K

Related Experiment Videos

Last Updated: Mar 16, 2026

Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing
10:19

Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing

Published on: February 13, 2016

11.9K
Physiology Lab Demonstration: Glomerular Filtration Rate in a Rat
06:58

Physiology Lab Demonstration: Glomerular Filtration Rate in a Rat

Published on: July 26, 2015

18.2K
A Modified EPA Method 1623 that Uses Tangential Flow Hollow-fiber Ultrafiltration and Heat Dissociation Steps to Detect Waterborne Cryptosporidium and Giardia spp.
12:11

A Modified EPA Method 1623 that Uses Tangential Flow Hollow-fiber Ultrafiltration and Heat Dissociation Steps to Detect Waterborne Cryptosporidium and Giardia spp.

Published on: July 9, 2012

21.1K

Area of Science:

  • Nephrology
  • Clinical Medicine
  • Dialysis Research

Background:

  • Fluid management is crucial for hemodialysis patients.
  • Ultrafiltration (UF) rate, the speed of fluid removal, is a key aspect of fluid management.
  • Observational data suggest higher UF rates correlate with adverse patient outcomes, potentially due to hypoperfusion-induced end-organ injury.

Purpose of the Study:

  • To evaluate the impact of lowering ultrafiltration (UF) rates on clinical and patient-centered outcomes in maintenance hemodialysis.
  • To address the lack of prospective clinical trial data on UF rate modification.
  • To inform the implementation of UF rate as a clinical performance measure.

Main Methods:

  • The abstract does not specify methods, as it highlights the need for prospective studies.
  • It discusses the challenges of lowering UF rates, including reducing interdialytic weight gain and extending dialysis duration.
  • Patient aversion to longer treatments and difficulty with weight gain reduction are noted barriers.

Main Results:

  • The abstract presents no direct results from a clinical trial.
  • It highlights that observational data associate higher UF rates with adverse outcomes.
  • The pathophysiological rationale for this association involves hypoperfusion and ischemic injury.

Conclusions:

  • Prospective studies are essential to determine the clinical and patient-centered effects of lowering UF rates before implementing UF rate limitations as a quality measure.
  • Current quality measures endorsed by the National Quality Forum may have unintended consequences, such as failed target weight achievement.
  • Further research is needed to balance the potential benefits of controlled fluid removal with patient tolerance and adherence.